APPLICATION
ANDA074732
TYPE
ANDA
ORIGINAL APPROVAL
2003-02-20
LATEST ACTION
2023-07-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
TAMOXIFEN CITRATEPrescription
TAMOXIFEN CITRATE EQ 20MG BASE · TABLET · ORAL
TAMOXIFEN CITRATEPrescription
TAMOXIFEN CITRATE EQ 10MG BASE · TABLET · ORAL
Approval history
2023-07-25Manufacturing (CMC) · Supplement 15 · unknownAP
2007-02-02Labeling · Supplement 6AP
2006-03-02Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.